Manmeet Soni - Dec 31, 2021 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role: COO and CFO
Signature: /s/ Tracy Herson, attorney-in-fact
Stock symbol: RETA
Transactions as of: Dec 31, 2021
Transactions value $: $419,565
Form type: 4
Date filed: 1/4/2022, 07:51 AM
Previous filing: May 21, 2021
Next filing: Jan 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Purchase	$420K	+16K	+533.33%	$26.22	19K	Dec 31, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on one day at prices ranging from $25.97 to $26.46. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions on one day at prices ranging from $25.97 to $26.46. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in this footnote.